Photobiomodulation for the treatment of retinal injury and retinal degenerative diseases

Janis T. Eells, Kristina D. DeSmet, Diana K. Kirk, Margaret Wong-Riley, Harry T. Whelan, James Ver Hoeve, T. Michael Nork, Jonathan Stone, Krisztina Valter

    Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

    19 Citations (Scopus)

    Abstract

    Retinal injury and retinal degenerative diseases are a leading causes of visual impairment in the developed world. Mitochondrial dysfunction and oxidative stress play key roles in the pathogenesis of retinal injury and disease. The development and testing of strategies designed to improve mitochondrial function and attenuate oxidative stress are essential for combating retinal disease. One strategy involves the use of photobiomodulation. Photobiomodulation, low-energy photon irradiation by light in the far-red to near-infrared (NIR) range using low energy lasers or light-emitting diode (LED) arrays, has been applied clinically in the treatment soft tissue injuries and acceleration of wound healing for more than 30 years. The therapeutic effects of photobiomodulation have been hypothesized to be mediated by intracellular signaling mechanisms triggered by the interaction of farred to NIR photons with the mitochondrial photoacceptor molecule cytochrome oxidase which culminate in improved mitochondrial energy metabolism, increased synthesis of cytoprotective factors and cell survival. The therapeutic potential of 670 nm LED photobiomodulation administered once per day at a fluence of 4 J/cm2 was investigated in established experimental models of retinal injury, retinal toxicity and retinal disease. Photobiomodulation stimulated retinal wound healing following high-intensity laser-induced retinal injury. Photobiomodulation not only enhanced the rate of wound healing, it also prevented the loss of retinal and cortical visual function induced by laser-induced retinal injury. In a rodent model of retinal mitochondrial toxicity, photobiomodulation preserved retinal function and prevented photoreceptor damage. Moreover, molecular studies revealed that photobiomodulation induced significant upregulation of gene expression pathways involved in mitochondrial energy production and cytoprotection in the retina. Retinitis pigmentosa is the leading cause of vision loss due to retinal degeneration. Photobiomodulation administered during the critical period of photoreceptor development in a rat model of retinitis pigmentosa increased retinal mitochondrial cytochrome oxidase activity, upregulated the production of retinal antioxidants, increased the production of retinal neurotrophic factors and prevented photoreceptor cell death. The molecular, biochemical and functional insights obtained from this research provide crucial information needed for a comprehensive FDA approval for the use of photobiomodulation in the treatment of retinal diseases. From a basic science perspective, they substantiate previous in vitro investigations and support the hypothesis that photobiomodulation augments mitochondrial function and stimulates cytoprotective pathways to prevent retinal damage. From a clinical perspective, they document the therapeutic potential of 670 nm photon therapy in experimental models of retinal injury, retinal toxicity and retinitis pigmentosa, thus setting the stage for clinical trials of photobiomodulation in human disease.

    Original languageEnglish
    Title of host publicationProceedings of Light-Activated Tissue Regeneration and Therapy Conference
    Pages39-51
    Number of pages13
    DOIs
    Publication statusPublished - 2008
    Event2nd Conference on "Light-Activated Tissue Regeneration and Therapy" an Engineering Conference International, ECI 2007 - Tomar, Portugal
    Duration: 24 Jun 200729 Jun 2007

    Publication series

    NameLecture Notes in Electrical Engineering
    Volume12 LNEE
    ISSN (Print)1876-1100
    ISSN (Electronic)1876-1119

    Conference

    Conference2nd Conference on "Light-Activated Tissue Regeneration and Therapy" an Engineering Conference International, ECI 2007
    Country/TerritoryPortugal
    CityTomar
    Period24/06/0729/06/07

    Fingerprint

    Dive into the research topics of 'Photobiomodulation for the treatment of retinal injury and retinal degenerative diseases'. Together they form a unique fingerprint.

    Cite this